Form D · Other
Neural Therapeutics Inc.
Toronto, A6 · CIK 0001912698
Offering snapshot reported Feb 22, 2022 · SEC filing
- Reported sold
- $591K Offering amount: $591K
- Investors reported
- 28 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 3, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 22, 2022 | Initial | $590,820 | No comparison | 28 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-434472
Source: Form D, filed Feb 22, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Ian Campbell | Director, Executive |
| John Durfy | Director |
| Robert Wilson | Executive |
Issuer details
Industry: Other (See others in industry)
Address:
77 King Street West Suite 2905
Toronto, A6, M5K 1H1
Toronto, A6, M5K 1H1